PRACA ORYGINALNA
Applications of Amniotic Membrane in Ophthalmology – New Perspectives in the Treatment of Eye Diseases
1
Department of Ophthalmology, National Institute of Medicine of the Ministry of Interior and Administration in Warsaw, Poland
Head: Joanna Sempińska-Szewczyk, MD, PhD
Data publikacji: 19-08-2024
Ophthalmology 2024;27(2):11-15
SŁOWA KLUCZOWE
STRESZCZENIE
Amniotic membrane, a natural protective barrier surrounding the fetus, possesses unique biological properties, making it a promising tool in regenerative medicine. It contains pluripotent cells, collagen, anti-inflammatory cytokines, and growth factors. This article aims to present the current state of knowledge regarding the potential applications of amniotic membrane in ophthalmology, as well as the benefits and challenges associated with this promising therapy. Amniotic membrane, used in the form of a graft or extract, exhibits anti-inflammatory effects, accelerates tissue healing, and regenerates corneal epithelium. In ophthalmology, amniotic membrane is used in the treatment of corneal ulcers, limbal stem cell deficiency, burns, strabismus, glaucoma, and neoplastic changes. It can also be used in the reconstruction of the ocular surface and in vitreoretinal surgery. Studies demonstrate its effectiveness in improving symptoms of dry eye syndrome. Additionally, new methods of combining amniotic membrane with the ocular surface are being introduced. Amniotic membrane is also used as a carrier in stem cell culture. The development of technology and research on amniotic membrane lead to the discovery of new applications and the improvement of surgical techniques, opening up prospects for even broader utilization of its potential in the future.
REFERENCJE (65)
1.
Davis JS: Skin Grafting at the Johns Hopkins Hospital. Annals of Surgery. 1909; 50(3): 542–549. doi:10.1097/00000658-190909000-00002.
2.
de Rotth A: Plastic Repair of Conjunctival Defects with Fetal Membranes. Archives of Ophthalmology. 1940; 23(3): 522–525. doi:10.1001/archopht.1940.00860130586006.
3.
Batlle JF, Perdomo FJ: Placental membranes as a conjunctival substitute. Ophthalmology. Published online 1993.
4.
Kim JC, Tseng SC: Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995; 14(5): 473–484.
5.
Koob TJ, Lim JJ, Zabek N, et al.: Cytokines in single layer amnion allografts compared to multilayer amnion/chorion allografts for wound healing. J Biomed Mater Res B Appl Biomater. 2015; 103(5): 1133–1140. doi:10.1002/jbm.b.33265.
6.
Baradaran-Rafii A, Asl NS, Ebrahimi M, et al.: The role of amniotic membrane extract eye drop (AMEED) in in vivo cultivation of limbal stem cells. Ocul Surf. 2018; 16(1): 146–153. doi:10.1016/j.jtos.2017.11.001.
7.
Dudok DV, Nagdee I, Cheung K, et al.: Effects of amniotic membrane extract on primary human corneal epithelial and limbal cells. Clin Exp Ophthalmol. 2015; 43(5): 443–448. doi:10.1111/ceo.12480.
8.
Dua HS, Rahman I, Miri A, et al.: Said DG: Variations in amniotic membrane: relevance for clinical applications. Br J Ophthalmol. 2010; 94(8): 963–964. doi:10.1136/bjo.2009.157941.
9.
He H, Li W, Chen SY, et al.: Suppression of activation and induction of apoptosis in RAW264.7 cells by amniotic membrane extract. Invest Ophthalmol Vis Sci. 2008; 49(10): 4468–4475. doi:10.1167/iovs.08-1781.
10.
Tighe S, Moein HR, Chua L, et al.: Topical Cryopreserved Amniotic Membrane and Umbilical Cord Eye Drops Promote Re-Epithelialization in a Murine Corneal Abrasion Model. Invest Ophthalmol Vis Sci. 2017; 58(3): 1586–1593. doi:10.1167/iovs.16-20834.
11.
Cheng AMS, Chua L, Casas V, et al.: Morselized Amniotic Membrane Tissue for Refractory Corneal Epithelial Defects in Cicatricial Ocular Surface Diseases. Trans Vis Sci Tech. 2016; 5(3): 9. doi:10.1167/tvst.5.3.9.
12.
Rennie K, Gruslin A, Hengstschläger M, et al.: Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine. Stem Cells Int. 2012; 2012: 721538. doi:10.1155/2012/721538.
13.
Röck T, Bartz-Schmidt KU, Landenberger J, et al.: Amniotic Membrane Transplantation in Reconstructive and Regenerative Ophthalmology. Ann Transplant. 2018; 23: 160–165. doi:10.12659/AOT.906856.
14.
Jirsova K, Jones GLA: Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting – a review. Cell Tissue Bank. 2017; 18(2): 193–204. doi:10.1007/s10561-017-9618-5.
15.
Malhotra C, Jain AK: Human amniotic membrane transplantation: Different modalities of its use in ophthalmology. WJT. 2014; 4(2): 111. doi:10.5500/wjt.v4.i2.111.
16.
Dua HS, Gomes JAP, King AJ, et al.: The amniotic membrane in ophthalmology. Survey of Ophthalmology. 2004; 49(1): 51–77. doi:10.1016/j.survophthal.2003.10.004.
17.
Liu J, Li L, Li X: Effectiveness of Cryopreserved Amniotic Membrane Transplantation in Corneal Ulceration: A Meta-Analysis. Cornea. 2019; 38(4): 454– 462. doi:10.1097/ICO.0000000000001866.
18.
Hick S, Demers PE, Brunette I, et al.: Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea. 2005; 24(4): 369–377. doi:10.1097/01.ico.0000151547.08113.d1.
19.
Takaoka M, Nakamura T, Sugai H, et al.: Sutureless amniotic membrane transplantation for ocular surface reconstruction with a chemically defined bioadhesive. Biomaterials. 2008; 29(19): 2923–2931. doi:10.1016/j.biomaterials.2008.03.027.
20.
Soeken TA, Zhu H, DeMartelaere S, et al.: Sealing of Corneal Lacerations Using Photoactivated Rose Bengal Dye and Amniotic Membrane. Cornea. 2018; 37(2): 211–217. doi:10.1097/ICO.0000000000001389.
21.
Kotomin I, Valtink M, Hofmann K, et al.: Sutureless fixation of amniotic membrane for therapy of ocular surface disorders. PLoS One. 2015; 10(5): e0125035. doi:10.1371/journal.pone.0125035.
22.
Shanbhag SS, Chodosh J, Saeed HN: Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome/toxic epidermal necrolysis. Ocul Surf. 2019; 17(3): 560–564. doi:10.1016/j.jtos.2019.03.001.
23.
Ma KN, Thanos A, Chodosh J, et al.: A Novel Technique for Amniotic Membrane Transplantation in Patients with Acute Stevens-Johnson Syndrome. Ocul Surf. 2016; 14(1): 31–36. doi:10.1016/j.jtos.2015.07.002.
24.
Schuerch K, Baeriswyl A, Frueh BE, et al.: Efficacy of Amniotic Membrane Transplantation for the Treatment of Corneal Ulcers. Cornea. 2020; 39(4): 479–483. doi:10.1097/ICO.0000000000002179.
25.
Tabatabaei SA, Soleimani M, Behrouz MJ, et al.: A randomized clinical trial to evaluate the usefulness of amniotic membrane transplantation in bacterial keratitis healing. Ocul Surf. 2017; 15(2): 218–226. doi:1016/j.jtos.2017.01.004.
26.
Fuchsluger T, Tuerkeli E, Westekemper H, et al.: Rate of epithelialisation and re-operations in corneal ulcers treated with amniotic membrane transplantation combined with botulinum toxin-induced ptosis. Graefes Arch Clin Exp Ophthalmol. 2007; 245(7): 955–964. doi:10.1007/s00417-006-0493-1.
27.
Khokhar S, Natung T, Sony P, et al.: Amniotic Membrane Transplantation in Refractory Neurotrophic Corneal Ulcers: A Randomized, Controlled Clinical Trial. Cornea. 2005; 24(6): 654–660. doi:10.1097/01.ico.0000153102.19776.80.
28.
Anderson DF, Prabhasawat P, Alfonso E, et al.: Amniotic Membrane Transplantation After the Primary Surgical Management of Band Keratopathy. Cornea. 2001; 20(4): 354–361. doi:10.1097/00003226-200105000-00004.
29.
Altiparmak UE, Oflu Y, Yildiz EH, et al.: Prospective Comparison of Two Suturing Techniques of Amniotic Membrane Transplantation for Symptomatic Bullous Keratopathy. American Journal of Ophthalmology. 2009; 147(3): 442–446.e1. doi:10.1016/j.ajo.2008.08.036.
30.
Pires RT, Tseng SC, Prabhasawat P, et al.: Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol. 1999; 117(10): 1291–1297. doi:10.1001/archopht.117.10.1291.
31.
Koizumi N, Sakamoto Y, Okumura N, et al.: Cultivated corneal endothelial cell sheet transplantation in a primate model. Invest Ophthalmol Vis Sci. 2007; 48(10): 4519–4526. doi:10.1167/iovs.07-0567.
32.
Fernandez-Buenaga R, Aiello F, Zaher SS, et al.: Twenty years of limbal epithelial therapy: an update on managing limbal stem cell deficiency. BMJ Open Ophthalmol. 2018; 3(1):e000164. doi:10.1136/bmjophth-2018-000164.
33.
Tandon R, Gupta N, Kalaivani M, et al.: Amniotic membrane transplantation as an adjunct to medical therapy in acute ocular burns. Br J Ophthalmol. 2011; 95(2): 199–204. doi:10.1136/bjo.2009.173716.
34.
Sharma N, Singh D, Maharana PK, et al.: Comparison of Amniotic Membrane Transplantation and Umbilical Cord Serum in Acute Ocular Chemical Burns: A Randomized Controlled Trial. Am J Ophthalmol. 2016; 168: 157–163. doi:10.1016/j.ajo.2016.05.010.
35.
Eslani M, Baradaran-Rafii A, Cheung AY, et al.: Amniotic Membrane Transplantation in Acute Severe Ocular Chemical Injury: A Randomized Clinical Trial. Am J Ophthalmol. 2019; 199: 209–215. doi:10.1016/j.ajo.2018.11.001.
36.
Oliphant H, Rajak SN: Dried amniotic membrane in fornix reconstruction. Clin Exp Ophthalmol. 2019; 47(8): 1090–1091. doi:10.1111/ceo.13566.
37.
Thatte S, Jain J: Fornix Reconstruction with Amniotic Membrane Transplantation: A Cosmetic Remedy for Blind Patients. J Ophthalmic Vis Res. 2016; 11(2): 193–197. doi:10.4103/2008-322X.183916.
38.
Ding J, Hou Z, Li Y, et al.: Eyelid and fornix reconstruction in abortive cryptophthalmos: a single-center experience over 12 years. Eye (Lond). 2017; 31(11): 1576–1581. doi:10.1038/eye.2017.94.
39.
Tseng S, Dipascuale M, Liu D, et al.: Intraoperative Mitomycin C and Amniotic Membrane Transplantation for Fornix Reconstruction in Severe Cicatricial Ocular Surface Diseases. Ophthalmology. 2005; 112(5): 896–903.e1. doi:10.1016/j.ophtha.2004.11.041.
40.
Ti SE, Tow SL, Chee SP: Amniotic membrane transplantation in entropion surgery. Ophthalmology. 2001; 108(7): 1209–1217. doi:10.1016/s0161-6420(01)00599-1.
41.
Becerra EM, Blanco G, Saornil MA, et al.: Hughes technique, amniotic membrane allograft, and topical chemotherapy in conjunctival melanoma with eyelid involvement. Ophthalmic Plast Reconstr Surg. 2005; 21(3): 238–240. doi:10.1097/01.iop.0000161993.33230.a8.
42.
Barabino S, Rolando M, Bentivoglio G, et al.: Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid. Ophthalmology. 2003; 110(3): 474–480. doi:10.1016/S0161-6420(02)01892-4.
43.
Honavar SG, Bansal AK, Sangwan VS, et al.: Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology. 2000; 107(5): 975–979. doi:10.1016/s0161-6420(00)00026-9.
44.
Niknejad H, Yazdanpanah G: Anticancer effects of human amniotic membrane and its epithelial cells. Med Hypotheses. 2014; 82(4): 488–489. doi:10.1016/j.mehy.2014.01.034.
45.
Agraval U, Rundle P, Rennie IG, et al.: Fresh frozen amniotic membrane for conjunctival reconstruction after excision of neoplastic and presumed neoplastic conjunctival lesions. Eye (Lond). 2017; 31(6): 884–889. doi:10.1038/eye.2016.322.
46.
Paridaens D, Beekhuis H, van Den Bosch W, et al.: Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br J Ophthalmol. 2001; 85(6): 658–661. doi:10.1136/bjo.85.6.658.
47.
Clearfield E, Muthappan V, Wang X, et al.: Conjunctival autograft for pterygium. Cochrane Database Syst Rev. 2016; 2(2): CD011349. doi:10.1002/14651858.CD011349.pub2.
48.
Akbari M, Soltani-Moghadam R, Elmi R, et al.: Comparison of free conjunctival autograft versus amniotic membrane transplantation for pterygium surgery. J Curr Ophthalmol. 2017; 29(4): 282–286. doi:10.1016/j.joco.2017.08.003.
49.
Prajna NV, Devi L, Seeniraj SK, et al.: Conjunctival Autograft Versus Amniotic Membrane Transplantation After Double Pterygium Excision: A Randomized Trial. Cornea. 2016; 35(6): 823–826. doi:10.1097/ICO.0000000000000812.
50.
Kassem RR, El-Mofty RMAM, Khodeir MM, et al.: A comparative study of different amniotic membrane orientations during extraocular muscle surgery in rabbits. Curr Eye Res. 2018; 43(3): 325–332. doi:10.1080/02713683.2017.1401645.
51.
Kassem RR, El-Mofty RMAM: Amniotic Membrane Transplantation in Strabismus Surgery. Curr Eye Res. 2019; 44(5): 451–464. doi:10.1080/02713683.2018.1562555.
52.
Yamada M, Shinoda K, Hatakeyama A, et al.: Fat adherence syndrome after retinal surgery treated with amniotic membrane transplantation. Am J Ophthalmol. 2001; 132(2): 280–282. doi:10.1016/s0002-9394(01)00930-8.
53.
Kersey JP, Vivian AJ: Mitomycin and amniotic membrane: a new method of reducing adhesions and fibrosis in strabismus surgery. Strabismus. 2008; 16(3): 116–118. doi:10.1080/09273970802405493.
54.
Tugcu B, Helvacioglu F, Yuzbasioglu E, et al.: Amniotic membrane in the management of strabismus reoperations. Jpn J Ophthalmol. 2013; 57(2): 239–244. doi:10.1007/s10384-012-0217-5.
55.
Craig JP, Nelson JD, Azar DT, et al.: TFOS DEWS II Report Executive Summary. The Ocular Surface. 2017; 15(4): 802–812. doi:10.1016/j.jtos.2017.08.003.
56.
McDonald MB, Sheha H, Tighe S, et al.: Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study. Clin Ophthalmol. 2018; 12: 677–681. doi:10.2147/OPTH.S162203.
57.
John T, Tighe S, Sheha H, et al.: Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease. Journal of Ophthalmology. 2017; 2017: 1–10. doi:10.1155/2017/6404918.
58.
Wang X, Khan R, Coleman A: Device-modified trabeculectomy for glaucoma. Cochrane Database Syst Rev. 2015; 2015(12): CD010472. doi:10.1002/14651858.CD010472.pub2.
59.
Sheha H, Kheirkhah A, Taha H: Amniotic Membrane Transplantation in Trabeculectomy With Mitomycin C for Refractory Glaucoma. Journal of Glaucoma. 2008; 17(4): 303–307. doi:10.1097/IJG.0b013e31815c3a47.
60.
Bochmann F, Azuara-Blanco A: Interventions for late trabeculectomy bleb leak. Cochrane Database Syst Rev. 2012; (9): CD006769. doi:10.1002/14651858.CD006769.pub2.
61.
Yazdani S, Mahboobipour H, Pakravan M, et al.: Adjunctive Mitomycin C or Amniotic Membrane Transplantation for Ahmed Glaucoma Valve Implantation: A Randomized Clinical Trial. Journal of Glaucoma. 2016; 25(5): 415–421. doi:10.1097/IJG.0000000000000256.
62.
Arnould L, Theillac V, Moran S, et al.: Recurrent Exposure of XEN Gel Stent Implant and Conjunctival Erosion. Journal of Glaucoma. 2019; 28(3): e37–e40. doi:10.1097/IJG.0000000000001146.
63.
Caporossi T, Pacini B, de Angelis L, et al.: Human Amniotic Membrane To Close Recurrent, High Myopic Macular Holes in Pathologic Myopia with Axial Length of ≥30 mm. Retina. 2020; 40(10): 1946–1954. doi:10.1097/IAE.0000000000002699.
64.
Ohno-Matsui K, Ichinose S, Nakahama Kichi, et al.: The effects of amniotic membrane on retinal pigment epithelial cell differentiation. Mol Vis. 2005; 11: 1–10.
65.
Caporossi T, Tartaro R, de Angelis L, et al.: A human amniotic membrane plug to repair retinal detachment associated with large macular tear. Acta Ophthalmologica. 2019; 97(8): 821–823. doi:10.1111/aos.14109.
Udostępnij
ARTYKUŁ POWIĄZANY
| eISSN: | 1689-362X |
| ISSN: | 1505-2753 |
Przetwarzamy dane osobowe zbierane podczas odwiedzania serwisu. Realizacja funkcji pozyskiwania informacji o użytkownikach i ich zachowaniu odbywa się poprzez dobrowolnie wprowadzone w formularzach informacje oraz zapisywanie w urządzeniach końcowych plików cookies (tzw. ciasteczka). Dane, w tym pliki cookies, wykorzystywane są w celu realizacji usług, zapewnienia wygodnego korzystania ze strony oraz w celu monitorowania ruchu zgodnie z Polityką prywatności. Dane są także zbierane i przetwarzane przez narzędzie Google Analytics (więcej).
Możesz zmienić ustawienia cookies w swojej przeglądarce. Ograniczenie stosowania plików cookies w konfiguracji przeglądarki może wpłynąć na niektóre funkcjonalności dostępne na stronie.
Możesz zmienić ustawienia cookies w swojej przeglądarce. Ograniczenie stosowania plików cookies w konfiguracji przeglądarki może wpłynąć na niektóre funkcjonalności dostępne na stronie.
